Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Binacea Pharma, Inc.
Scientific Title
A Phase 1 Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BNA035 in Patients With Advanced Solid Tumors